Maridebart cafraglutide Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: AMG 133, MariTide

Filter by location:

Birmingham, Alabama1 trial

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

University of Alabama at Birmingham

Phase 3

Chula Vista, California1 trial

A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus

ProSciento, Inc. - Main Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.